Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Small Pharma Inc V.DMT

Small Pharma Inc. is a biotechnology company focused on short-duration psychedelic therapies for mental health conditions. The Company is focused on developing short-duration psychedelic-assisted therapies for the treatment of mental health conditions that are scalable, commercially differentiated, and conveniently dosed, with the goal of addressing key unmet needs in the treatment of depression. It has a portfolio of clinical-stage dimethyltryptamine (DMT)-based assets, SPL026 and SPL028. It has a pipeline of proprietary preclinical assets. Its clinical-stage program, SPL026, a first-generation DMT molecule, has shown proof-of-concept for the potential treatment of MDD. In a Phase IIa study, IV SPL026 demonstrated a rapid and durable antidepressant effect, as well as a favorable safety and tolerability profile. Small Pharma is also advancing SPL028, a second-generation injectable deuterated DMT molecule, in a Phase I trial.


TSXV:DMT - Post by User

Comment by GillRipperon Sep 14, 2022 2:03pm
72 Views
Post# 34962313

RE:Share Buy Back In Full Swing

RE:Share Buy Back In Full SwingAs of 11:00 Am 

Company looks to be buying again theu 8

Kind Regards To All

The Gipper

House Positions for C:DMT from 20220914 to 20220914
House Bought $Val Ave Sold $Val Ave Net $Net
8 Eight 950,000 142,500 0.15 0   950,000 -142,500
79 CIBC 101,550 15,412 0.152 12,000 1,880 0.157 89,550 -13,532
150 IACP 36,500 5,580 0.153 500 75 0.15 36,000 -5,505
85 Scotia 25,000 3,750 0.15 0   25,000 -3,750
124 Questrade 20,000 3,400 0.17 0   20,000 -3,400
89 Raymond James 17,000 2,774 0.163 0   17,000 -2,774
33 Canaccord 39,000 5,855 0.15 23,500 3,525 0.15 15,500 -2,330
9 BMO Nesbitt 9,000 1,395 0.155 0   9,000 -1,395
19 Desjardins 7,500 1,149 0.153 0   7,500 -1,149
57 Interactive 440 72 0.164 0   440 -72
1 Anonymous 157,900 24,028 0.152 158,000 24,739 0.157 -100 711
62 Haywood 1,000 147 0.147 1,140 185 0.162 -140 38
22 Fidelity 1,000 170 0.17 1,500 225 0.15 -500 55
14 Virtu ITG 4,823 723 0.15 7,723 1,173 0.152 -2,900 450
2 RBC 10,000 1,510 0.151 29,000 4,462 0.154 -19,000 2,952
80 National Bank 16,342 2,513 0.154 41,342 6,196 0.15 -25,000 3,683
7 TD Sec 2,587 424 0.164 113,437 16,933 0.149 -110,850 16,509
13 Instinet 0   1,011,500 152,012 0.15 -1,011,500 152,012
TOTAL 1,399,642 211,402 0.151 1,399,642 211,405 0.151 0 3

<< Previous
Bullboard Posts
Next >>